Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study).
The French healthcare system is a universal healthcare system with no financial barrier to access to health services and cancer drugs. The objective of the study is to investigate associations between, on the one hand, incidence and survival of patients diagnosed with lung cancer in France and, on t...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5571949?pdf=render |
id |
doaj-4c7565b0d1ce481980192cfea894b4bf |
---|---|
record_format |
Article |
spelling |
doaj-4c7565b0d1ce481980192cfea894b4bf2020-11-24T21:48:15ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01128e018279810.1371/journal.pone.0182798Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study).Christos ChouaïdDidier DebieuvreIsabelle Durand-ZaleskiJérôme FernandesArnaud ScherpereelVirginie WesteelCécile BleinAnne-Françoise GaudinNicolas OzanSoline LeblancAlexandre VainchtockPierre ChauvinFrançois-Emery CottéPierre-Jean SouquetThe French healthcare system is a universal healthcare system with no financial barrier to access to health services and cancer drugs. The objective of the study is to investigate associations between, on the one hand, incidence and survival of patients diagnosed with lung cancer in France and, on the other, the socioeconomic deprivation and population density of their municipality of residence. A national, longitudinal analysis using data from the French National Hospital database crossed with the population density of the municipality and a social deprivation index based on census data aggregated at the municipality level. For lung cancer diagnosed at the metastatic stage, one-year and two-year survival was not associated with the population density of the municipality of residence. In contrast, mortality was higher for people living in very deprived, deprived and privileged areas compared to very privileged areas (hazard ratios at two years: 1.19 [1.13-1.25], 1.14 [1.08-1.20] and 1.10 [1.04-1.16] respectively). Similar associations are also observed in patients diagnosed with non-metastatic disease (hazard ratios at two years: 1.21 [1.13-1.30], 1.15 [1.08-1.23] and 1.10 [1.03-1.18] for people living in very deprived, deprived and privileged areas compared to very privileged areas). Despite a universal healthcare coverage, survival inequalities in patients with lung cancer can be observed in France with respect to certain socioeconomic indicators.http://europepmc.org/articles/PMC5571949?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Christos Chouaïd Didier Debieuvre Isabelle Durand-Zaleski Jérôme Fernandes Arnaud Scherpereel Virginie Westeel Cécile Blein Anne-Françoise Gaudin Nicolas Ozan Soline Leblanc Alexandre Vainchtock Pierre Chauvin François-Emery Cotté Pierre-Jean Souquet |
spellingShingle |
Christos Chouaïd Didier Debieuvre Isabelle Durand-Zaleski Jérôme Fernandes Arnaud Scherpereel Virginie Westeel Cécile Blein Anne-Françoise Gaudin Nicolas Ozan Soline Leblanc Alexandre Vainchtock Pierre Chauvin François-Emery Cotté Pierre-Jean Souquet Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study). PLoS ONE |
author_facet |
Christos Chouaïd Didier Debieuvre Isabelle Durand-Zaleski Jérôme Fernandes Arnaud Scherpereel Virginie Westeel Cécile Blein Anne-Françoise Gaudin Nicolas Ozan Soline Leblanc Alexandre Vainchtock Pierre Chauvin François-Emery Cotté Pierre-Jean Souquet |
author_sort |
Christos Chouaïd |
title |
Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study). |
title_short |
Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study). |
title_full |
Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study). |
title_fullStr |
Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study). |
title_full_unstemmed |
Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study). |
title_sort |
survival inequalities in patients with lung cancer in france: a nationwide cohort study (the territoire study). |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2017-01-01 |
description |
The French healthcare system is a universal healthcare system with no financial barrier to access to health services and cancer drugs. The objective of the study is to investigate associations between, on the one hand, incidence and survival of patients diagnosed with lung cancer in France and, on the other, the socioeconomic deprivation and population density of their municipality of residence. A national, longitudinal analysis using data from the French National Hospital database crossed with the population density of the municipality and a social deprivation index based on census data aggregated at the municipality level. For lung cancer diagnosed at the metastatic stage, one-year and two-year survival was not associated with the population density of the municipality of residence. In contrast, mortality was higher for people living in very deprived, deprived and privileged areas compared to very privileged areas (hazard ratios at two years: 1.19 [1.13-1.25], 1.14 [1.08-1.20] and 1.10 [1.04-1.16] respectively). Similar associations are also observed in patients diagnosed with non-metastatic disease (hazard ratios at two years: 1.21 [1.13-1.30], 1.15 [1.08-1.23] and 1.10 [1.03-1.18] for people living in very deprived, deprived and privileged areas compared to very privileged areas). Despite a universal healthcare coverage, survival inequalities in patients with lung cancer can be observed in France with respect to certain socioeconomic indicators. |
url |
http://europepmc.org/articles/PMC5571949?pdf=render |
work_keys_str_mv |
AT christoschouaid survivalinequalitiesinpatientswithlungcancerinfranceanationwidecohortstudytheterritoirestudy AT didierdebieuvre survivalinequalitiesinpatientswithlungcancerinfranceanationwidecohortstudytheterritoirestudy AT isabelledurandzaleski survivalinequalitiesinpatientswithlungcancerinfranceanationwidecohortstudytheterritoirestudy AT jeromefernandes survivalinequalitiesinpatientswithlungcancerinfranceanationwidecohortstudytheterritoirestudy AT arnaudscherpereel survivalinequalitiesinpatientswithlungcancerinfranceanationwidecohortstudytheterritoirestudy AT virginiewesteel survivalinequalitiesinpatientswithlungcancerinfranceanationwidecohortstudytheterritoirestudy AT cecileblein survivalinequalitiesinpatientswithlungcancerinfranceanationwidecohortstudytheterritoirestudy AT annefrancoisegaudin survivalinequalitiesinpatientswithlungcancerinfranceanationwidecohortstudytheterritoirestudy AT nicolasozan survivalinequalitiesinpatientswithlungcancerinfranceanationwidecohortstudytheterritoirestudy AT solineleblanc survivalinequalitiesinpatientswithlungcancerinfranceanationwidecohortstudytheterritoirestudy AT alexandrevainchtock survivalinequalitiesinpatientswithlungcancerinfranceanationwidecohortstudytheterritoirestudy AT pierrechauvin survivalinequalitiesinpatientswithlungcancerinfranceanationwidecohortstudytheterritoirestudy AT francoisemerycotte survivalinequalitiesinpatientswithlungcancerinfranceanationwidecohortstudytheterritoirestudy AT pierrejeansouquet survivalinequalitiesinpatientswithlungcancerinfranceanationwidecohortstudytheterritoirestudy |
_version_ |
1725893193849896960 |